News & Updates

Show Multimedia Only

High incidence of chemo-related ADRs noted in multiple myeloma patients

24 Oct 2025

A single-institution study has found a notably high incidence of chemotherapy-related adverse drug reactions (ADRs) in patients with multiple myeloma.

High incidence of chemo-related ADRs noted in multiple myeloma patients

24 Oct 2025

Polygenic risk score shows promise in predicting future breast cancer events

23 Oct 2025 by

A retrospective analysis shows the potential of the 313-SNP breast cancer (BC) polygenic risk score (PRS313) blood test to predict future in situ or invasive breast disease in women diagnosed with ductal carcinoma in situ (DCIS) or lobular carcinoma in situ (LCIS).

Polygenic risk score shows promise in predicting future breast cancer events

23 Oct 2025

Adjuvant cemiplimab prolongs DFS in cutaneous SCC

22 Oct 2025 by

In the phase III C-POST trial, adjuvant cemiplimab prolongs disease-free survival (DFS) in individuals at high risk for recurrence of cutaneous squamous cell carcinoma (cSCC).

Adjuvant cemiplimab prolongs DFS in cutaneous SCC

22 Oct 2025

Cardiac irradiation, anthracyclines linked to VHD risk in childhood cancer survivors

21 Oct 2025

Higher doses of heart radiation therapy (RT) and anthracyclines contribute to an increased risk of valvular heart disease (VHD) in childhood cancer survivors, as suggested in a nested case-control study.

Cardiac irradiation, anthracyclines linked to VHD risk in childhood cancer survivors

21 Oct 2025

Early check-in protocol improves adherence to anticancer medications

20 Oct 2025

The implementation of an early check-in protocol may enable pharmacists of health-system specialty pharmacies (HSSPs) to enhance patient adherence to oral anticancer medication (OAM), suggests a recent study.

Early check-in protocol improves adherence to anticancer medications

20 Oct 2025

Deep learning-based model shows promise for personalizing ESCC treatment

17 Oct 2025 by

A retrospective analysis shows the ability of Vision-Mamba (Vim), a novel deep-learning (DL) model, to predict pathologic complete response (pCR) in individuals with esophageal squamous cell carcinoma (ESCC) following neoadjuvant immunotherapy and chemotherapy (nICT).

Deep learning-based model shows promise for personalizing ESCC treatment

17 Oct 2025

Frontline nelitolimod plus pembrolizumab combo elicits response in advanced melanoma

14 Oct 2025

The toll-like receptor 9 agonist nelitolimod, when combined with pembrolizumab, shows promising antitumour activity in treatment-naïve patients with anti–PD-1/PD-L1 advanced melanoma, according to a phase II open-label trial.

Frontline nelitolimod plus pembrolizumab combo elicits response in advanced melanoma

14 Oct 2025

Statins augment survival in prostate cancer patients on an ARPI

10 Oct 2025 by

Among prostate cancer patients receiving treatment with the androgen receptor pathway inhibitor (ARPI) apalutamide, those who also use statins appear to have longer overall survival, according to a study.

Statins augment survival in prostate cancer patients on an ARPI

10 Oct 2025

Electroacupuncture reduces early urinary incontinence burden after RP

10 Oct 2025

Electroacupuncture helps reverse urinary incontinence following radical prostatectomy (RP) for prostate cancer, according to a study from China.

Electroacupuncture reduces early urinary incontinence burden after RP

10 Oct 2025

Model predicts cardiomyopathy risk in childhood cancer survivors

09 Oct 2025

Researchers have recently developed prediction models with highest-to-date performance to estimate the 10-year risk of cardiomyopathy in long-term survivors of childhood cancer.

Model predicts cardiomyopathy risk in childhood cancer survivors

09 Oct 2025

News & Updates

Filter by Specialty:

Specialty:

High incidence of chemo-related ADRs noted in multiple myeloma patients

High incidence of chemo-related ADRs noted in multiple myeloma patients

Polygenic risk score shows promise in predicting future breast cancer events

Polygenic risk score shows promise in predicting future breast cancer events

Adjuvant cemiplimab prolongs DFS in cutaneous SCC

Adjuvant cemiplimab prolongs DFS in cutaneous SCC

Cardiac irradiation, anthracyclines linked to VHD risk in childhood cancer survivors

Cardiac irradiation, anthracyclines linked to VHD risk in childhood cancer survivors

Early check-in protocol improves adherence to anticancer medications

Early check-in protocol improves adherence to anticancer medications

Deep learning-based model shows promise for personalizing ESCC treatment

Deep learning-based model shows promise for personalizing ESCC treatment

Frontline nelitolimod plus pembrolizumab combo elicits response in advanced melanoma

Frontline nelitolimod plus pembrolizumab combo elicits response in advanced melanoma

Statins augment survival in prostate cancer patients on an ARPI

Statins augment survival in prostate cancer patients on an ARPI

Electroacupuncture reduces early urinary incontinence burden after RP

Electroacupuncture reduces early urinary incontinence burden after RP

Model predicts cardiomyopathy risk in childhood cancer survivors

Model predicts cardiomyopathy risk in childhood cancer survivors